Literature DB >> 16508624

Resection of colorectal liver metastases: current perspectives.

James M McLoughlin1, Eric H Jensen, Mokenge Malafa.   

Abstract

BACKGROUND: Metastases to the liver is the leading cause of death in patients with colorectal cancer.
METHODS: The authors review the data on diagnosis and management of this clinical problem, and they discuss management options that can be considered.
RESULTS: Complete surgical resection of metastases from colorectal cancer that are localized to the liver results in 5-year survival rates ranging from 26% to 40%.
CONCLUSIONS: By adding modalities such as targeted systemic therapy and other "local" treatments for liver metastases, further gains in survival are anticipated.

Entities:  

Mesh:

Year:  2006        PMID: 16508624     DOI: 10.1177/107327480601300105

Source DB:  PubMed          Journal:  Cancer Control        ISSN: 1073-2748            Impact factor:   3.302


  17 in total

1.  Liver resection with intraoperative and laparoscopic ultrasound: report of 32 cases : Ultrasonic shears device for liver parenchymal transection.

Authors:  Domenico Piccolboni; Francesco Ciccone; Anna Settembre; Francesco Corcione
Journal:  Surg Endosc       Date:  2008-04-10       Impact factor: 4.584

2.  Vascular profile characterization of liver tumors by magnetic resonance imaging using hemodynamic response imaging in mice.

Authors:  Yifat Edrei; Eitan Gross; Nathalie Corchia; Galia Tsarfaty; Eithan Galun; Orit Pappo; Rinat Abramovitch
Journal:  Neoplasia       Date:  2011-03       Impact factor: 5.715

Review 3.  Update and review of the multidisciplinary management of stage IV colorectal cancer with liver metastases.

Authors:  Sherif Raafat Zikry Abdel-Misih; Carl R Schmidt; Paul Mark Bloomston
Journal:  World J Surg Oncol       Date:  2009-09-29       Impact factor: 2.754

4.  Prognostic value of β1 integrin expression in colorectal liver metastases.

Authors:  Nikolaos Vassos; Tilman Rau; Susanne Merkel; Fabian Feiersinger; Carol I Geppert; Michael Stürzl; Werner Hohenberger; Roland S Croner
Journal:  Int J Clin Exp Pathol       Date:  2013-12-15

5.  Current diagnostic and therapeutic approaches for colorectal cancer liver metastasis.

Authors:  K A Paschos; N Bird
Journal:  Hippokratia       Date:  2008-07       Impact factor: 0.471

Review 6.  Immunotherapy for gastrointestinal malignancies.

Authors:  Paul G Toomey; Nasreen A Vohra; Tomar Ghansah; Amod A Sarnaik; Shari A Pilon-Thomas
Journal:  Cancer Control       Date:  2013-01       Impact factor: 3.302

7.  Electrocoagulation for liver metastases.

Authors:  Dawid Storman; Mateusz J Swierz; Robert P Riemsma; Robert Wolff; Jerzy W Mitus; Michal Pedziwiatr; Jos Kleijnen; Malgorzata M Bala
Journal:  Cochrane Database Syst Rev       Date:  2021-01-28

8.  Improved efficacy of a novel anti-angiogenic drug combination (TL-118) against colorectal-cancer liver metastases; MRI monitoring in mice.

Authors:  Y Edrei; E Gross; N Corchia; R Abramovitch
Journal:  Br J Cancer       Date:  2012-07-17       Impact factor: 7.640

9.  Targeting the angiotensin II type 2 receptor (AT2R) in colorectal liver metastases.

Authors:  Eleanor I Ager; Way W Chong; Shu-Wen Wen; Christopher Christophi
Journal:  Cancer Cell Int       Date:  2010-06-28       Impact factor: 5.722

10.  Altered efficacy of AT1R-targeted treatment after spontaneous cancer cell-AT1R upregulation.

Authors:  Eleanor I Ager; Shu Wen Wen; Joyna Chan; Way W Chong; Jaclyn H Neo; Christopher Christophi
Journal:  BMC Cancer       Date:  2011-06-26       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.